| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |